Atlas Trials

Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage

Clinical trial NCT01179529 · COMPLETED

Trial details

NCT number
NCT01179529
Sponsor
Technical University of Munich
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic DermatitisAtopic Eczema

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.